AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06486116 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Task Specific Physical Therapy Home Program
Description: Home exercise program based on specific findings from physical therapy evaluations.
Study NCT06314503 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WEAKID
Description: Six treatments over the course of two weeks with the WEAKID system:~* Week 1 (without the sorbents)~  * Day 1: four-hour treatment~ * Day 2: eight-hour treatment~ * Day 3: eight-hour treatment~* Week 2 (with the sorbents)~  * Day 1: four-hour treatment~ * Day 2: eight-hour treatment~ * Day 3: eight-hour treatment
Study NCT05020548 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: peak inspiratory pressure 10 cmH2O
Description: pressure controlled mask ventilation with peak inspiratory pressure of 10 cmH2O
Study NCT05020548 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: peak inspiratory pressure 15 cmH2O
Description: pressure controlled mask ventilation with peak inspiratory pressure of 15 cmH2O
Study NCT05020548 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: peak inspiratory pressure 20 cmH2O
Description: pressure controlled mask ventilation with peak inspiratory pressure of 20 cmH2O
Study NCT04849988 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABP-450
Description: ABP-450 (prabotulinumtoxinA) contains a 900kDA botulinum toxin type-A complex produced by the bacterium Clostridium botulinum.
Study NCT04849988 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% sodium chloride, sterile, unpreserved, USP/Ph.Eur.
Study NCT06165900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adebrelimab plus stereotactic radiotherapy followed by adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin)
Description: Adebrelimab plus radiotherapy phase: radiotherapy was started on the day of the second cycle of adebrelimab administration every other day for 3 fractions; Adebrelimab plus chemotherapy phase: starting within 3-5 weeks after completion of radiotherapy, every 3 weeks for 6 cycles.
Study NCT06165900 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin)
Description: adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin)
Study NCT04933825 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ET-02
Description: A conditioning therapy with cyclophosphamide and fludarabine will be conducted before ET-02 injection.
Study NCT05369871 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Closed-loop system
Description: Closed-loop system consisting of a terminal including the Diabeloop algorithm that is associated with the Dexcom G6 CGM and the Accu-Chek Insight insulin pump.
Study NCT05369871 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Open-loop system
Description: Open-loop system consisting of a terminal without the Diabeloop algorithm that is associated with the Dexcom G6 CGM and the usual insulin pump.
Study NCT04927533 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ronnie Gardiner Method
Description: The Ronnie Gardiner Method (RGM), developed in 1993 by Swedish jazz drummer Ronnie Gardiner, is a promising multimodal, music-based intervention with potential to stimulate and improve several cognitive functions, motor skills, reading and speech skills and social interaction. RGM participants are required to follow (what is known as) choreoscores. This is a visual representation of the sequence of movements using four unique symbols. Each symbol represents a body half via color (red = left side, blue = right side) and the use of a body part via shape (the symbols resemble hands or feet). In addition, each movement has a specific name, based on drum sounds, which must be pronounced simultaneously. The exercises are guided by trained 'RGM-practitioners'. The course and difficulty of the session can be adapted in different ways by the RGM Practitioner, according to the capabilities of the participants.
Study NCT05381623 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Simplified suture-less approach
Description: Immediately after the harvest of a free gingival graft from hard palate, at least a half carpule of local anesthetic (articaine 4% 1:100.000 epinephrine) will be infiltrated within the apical border of the harvesting site and another half mesially and distally to the harvesting site. At the end of the mucogingival procedure, the donor site will be evaluated to inquire regarding the presence of a competent coagulum over the wound area. In such a case, no additional procedure will be performed at the recipient site.
Study NCT05381623 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Application of hemostatic sponges and compressive sutures
Description: Immediately after the harvest of a free gingival graft from hard palate, hemostatic collagen sponges will be applied over the harvesting site and a series of tooth suspended external mattress sutures (PGA 5/0) will be applied over the area, in order to provide a compressive effect.
Study NCT05896956 — intervention group
Intervention type: OTHER
Intervention: no interventions
Description: no interventions
Study NCT06029036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Darolutamide+ADT
Description: Drug: Darolutamide~Darolutamide 600 mg, (two 300 mg tablets) administered orally twice daily. Swallow tablets whole. Take Darolutamide with food.~Drug: ADT GnRH agonist per physicians' choice, orchiectomy is excluded
Study NCT02232100 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attentional bias modification training (AMG)
Description: Attentional bias modification, administered via an internet-delivered visual-probe task that trains attention away from pain-related information
Study NCT02232100 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Attentional bias placebo (ACG)
Description: Attentional bias placebo, administered via an internet-delivered visual-probe task that does not train attention either away or towards pain-related information
Study NCT05400876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB2618 injection
Description: TQB2618 injection is an inhibitor of T cell immunoglobulin and mucin domain-containing protein 3 (TIM3)
Study NCT05400876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Penpulimab injection
Description: Penpulimab is an inhibitor of programmed cell death protein 1 (PD-1)
Study NCT06485375 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: EMG
Description: Disposable bipolar surface electrodes will be used. The patient's skin will be clean with cotton gauze soaked in alcohol before electrodes placement to reduce skin impedance. The operator will palpate the muscle belly while the patient clenches his teeth and will position surface electrodes in parallel to the muscular fibres. Doing so the position of the electrodes results as follows: Masseters electrodes will be fixed parallel to the exocanthion-gonion line and with the upper pole of the electrode under the tragus-labial commissural line. Temporalis electrodes will be positioned along the anterior margin of the muscle (corresponding to the frontoparietal suture). Suprahyoid muscles electrodes will be placed in the submental area nearly 1 cm posterior to the mental symphysis, paramedian to the midline and lightly diverging. A reference electrode will be applied to the forehead of the patient.
Study NCT05493007 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sandbag motion style acupuncture treatment
Description: Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of their body actively during acupuncture treatment under physicians' observation.
Study NCT05493007 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Korean medical treatment
Description: acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine.
Study NCT05493007 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Korean medical treatment
Description: acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine.
Study NCT05353764 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: scalp nerve block combined with intercostal nerve block using 0.5% ropivacaine
Description: Participants randomized to the SNB group will receive general anesthesia combined with scalp nerve block and intercostal nerve block with 0.5% ropivacaine, which was performed exclusively by an attending anesthesiologist.An attending anesthesiologist will select the site of SNB based on the surgical incision site. Scalp nerve was blocked including greater occipital nerve (2-3ml), superficial temporal nerve (2-3ml), trochlear nerve (2-3ml) and supraorbital nerve (2-3ml). The total volume in scalp nerve block will not exceed 10 ml.Ultrasound-guided unilateral ICNB will be performed at the level of T4-T5 next to the sternum.10-15ml of 0.5% ropivacaine will be injected into the intercostal spaces where incision locates after negative aspiration.
Study NCT06139003 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 3d Printed implant
Description: Occlusal stability was evaluated using occlusense device by charting amount and distribution of force over dental arch in percentage
Study NCT06139003 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Conventionally constructed implant
Description: Occlusal stability was evaluated using occlusense device by charting amount and distribution of force over dental arch in percentage
Study NCT05155306 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894, intended Commercial Formulation (iCF) (T)
Description: Test Treatment (T)
Study NCT05155306 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894, Trial Formulation 2 (TFII) (R)
Description: Reference Treatment (R)
Study NCT05274711 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole body vibration training
Description: The participants will be instructed to stand on the vibration platform bare footed and distribute their weight evenly on both feet (fig 3). Next, they will be asked to do a head and neck retraction while looking forward with their knees at 30 degrees of flexion. In order to prevent fatigue in the subject's cervical area due to holding their head and neck in retraction, they will be asked to hold this position for 15 seconds then rest for 5 seconds. Since each set will last 60 second this allowed the subjects to do 3 retractions in each set. In total each subject will perform 15 retractions during the training. The subjects will experience a vertical vibration at a frequency and amplitude of 30 Hz and 4 mm during the sets (Salami et al., 2018).
Study NCT05274711 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical treatment
Description: Posturalcorrectionexercisesintheformofstretchingandstrengthening exercise. Manual stretching exercises as passive stretch to (upper trapezius, levator scapulae, sub occipitalis, scalene, sternocleidomastoid, and pectoralis major muscles), 30 seconds of 3-5 repetitions for each muscle, followed by 30 seconds of rest, as well as isotonic exercises (to strength deep neck flexors and scapular retractor muscles) 3 sets of 12 repetitions each with a 6 second hold in between, with a 1-2-minute rest between sets (Kisner. and Colby 2012).
Study NCT05274711 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical treatment
Description: Posturalcorrectionexercisesintheformofstretchingandstrengthening exercise. Manual stretching exercises as passive stretch to (upper trapezius, levator scapulae, sub occipitalis, scalene, sternocleidomastoid, and pectoralis major muscles), 30 seconds of 3-5 repetitions for each muscle, followed by 30 seconds of rest, as well as isotonic exercises (to strength deep neck flexors and scapular retractor muscles) 3 sets of 12 repetitions each with a 6 second hold in between, with a 1-2-minute rest between sets (Kisner. and Colby 2012).
Study NCT06123520 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ho-YAG Laser Visual internal urethrotomy
Description: the operations will be performed by an expert surgeon and operative time will be considered. The procedure will be performed under spinal or general anaesthesia in lithotomy position. Antibiotic will be given just before and 12 h after procedure and continued for next 5 days.~Normal saline will be used for irrigation during the procedure. A Holmium laser at an energy of 1,200 to 2.000 mJ with a frequency of 10 to 15 Hz will be used By use of a 22 F cystoscope and Ho:YAG laser, the stricture site will be completely incised while sparing healthy mucosa. a fiber will be positioned about 1 mm away from the tissue and the laser will be fired.~An 18 F silicone Foley catheter will be left in the urethra at the end of the procedure. urethral catheter removal and voiding trial will be given at postoperative Day 7.
Study NCT06123520 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ho-YAG Laser Visual internal urethrotomy combined with intralesional submucosal injection of Paclitaxel
Description: The investigators will follow the same interversion protocol in the first group then paclitaxel is going to be injected via Williams cystoscopic injection needle (5 F size and 23 G needle size) through the cystoscope after laser ablation of the stricture in the submucosa with an assumed dose of 3.5µg/mm2 (reaching a urethral diameter of 30 Fr and a total length of 2 cm a total dose of 2.2 mg divided along 3 injection is to be injected). the dose is divided at 12,4 and 8 o'clock respectively along the length of the stricture.~An 18 F silicone Foley catheter will be left in the urethra at the end of the procedure. urethral catheter removal and voiding trial will be given at postoperative Day 7.
Study NCT05524103 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALMB-0166
Description: A single dose of ALMB-0166 injection.
Study NCT05524103 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ALMB-0166
Description: A single dose of ALMB-0166 injection.
Study NCT05584475 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Awareness Practices (MAPs)
Description: MAPs is an 8-session, group-based approach for individuals with ADHD to improve attentional difficulties and related impairments by enhancing attending to and accepting experiences in the present moment. Sessions typically last between 60 and 90 minutes, though may last up to 120 minutes.
Study NCT05717699 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ad-TD-nsIL12
Description: After stereotactic biopsy, the Ommaya reservoir will be inserted through the biopsy channel and two injections of Ad-TD-nsIL12 will be delivered after surgery by Ommaya reservoir (with an interval of 3days). The interval between following injections in the subsequent treatment period will be 3 weeks ±4 days. The assigned dose for each patient will be 3x10\^9vp, 1x10\^10vp or 3x10\^10 vp suspended in 1 ml NS according to cohort design.
Study NCT05764044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin, gemcitabine
Description: Two additional cycles of cisplatin-based adjuvant chemotherapy 50mg/m2 D1 and gemcitabine 1000mg/m2 D1 and D8 at every 21 days.
Study NCT05764044 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Follow-up
Description: Patients will be followed with plasma cfDNA-HPV, computed tomography (CT) scan of the thorax and magnetic resonance (MRI) of abdomen and pelvis and clinical and gynecological examination at every four months.
Study NCT05764044 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Follow-up
Description: Patients will be followed with plasma cfDNA-HPV, computed tomography (CT) scan of the thorax and magnetic resonance (MRI) of abdomen and pelvis and clinical and gynecological examination at every four months.
Study NCT05909475 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: GKEX
Description: GKEX group. Probiotic capsules contain 10 billion CFU (colony forming units) of GKEX, , 2 caps daily use.
Study NCT05909475 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo capsule contains microcrystalline cellulose, 2 caps daily use.
Study NCT05231642 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional Interventional
Description: Individualised postprandial glucose and vascular risk responses
Study NCT05456074 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Retrospective data collection
Study NCT06357338 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: No intervention
Study NCT05227625 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: body dissatisfaction management group
Description: Our group is composed of 10 weekly session of 2 hours led by a psychologist trained in the management of ED and ACT therapy.~Each group will be composed of 5 to 10 people. First of all, the group will lead the participants to better know and understand the impact of BD on the symptomatology of ED by teaching current scientific knowledge on the subject. In a second step, the group will guide the patients in the acquisition of psychological skills to deal with events related to BD and to engage in actions towards the values that give meaning to their existence.
Study NCT05227625 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation Group
Description: Participants will be included in a standardized relaxation program consisting of a weekly 2 hour session for 10 weeks. The group will be led by a psychologist trained in relaxation and in particular in abdominal and muscular relaxation techniques. Each group will be composed of 5 to 10 people. Initially, the therapy will lead the participants to recognize the signs of anxiety and to understand the physiological mechanisms involved. Classic techniques of anxiety management will then be introduced (cardiac coherence, abdominal and muscular relaxation, Jacobson technique, Schultz autogenic training). These techniques will be tested in session. Participants will be encouraged to practice these techniques at home.
Study NCT05229757 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy and rehabilitation treatment in a special education and rehabilitation center.
Description: Routine physiotherapy and rehabilitation practice was performed 2 days a week for 8 weeks in the special education and rehabilitation center.
Study NCT05229757 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Family-based home exercise.
Description: Home exercise was applied by the families every day of the week for 8 weeks.
Study NCT05182632 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group pelvic floor telerehabilitation
Description: Multimodal group physiotherapy: 12 weeks of weekly group physiotherapy treatments including education and pelvic floor muscle exercises delivered online + home exercise program
Study NCT04888910 — intervention group
Intervention type: OTHER
Intervention: observational
Description: observation of biomarkers in different asthma groups
Study NCT06336863 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Allosure and TruGraf
Description: Precision medicine will be employed to withdraw immunosuppression in kidney transplant recipients.
Study NCT06336863 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Allosure and TruGraf
Description: Precision medicine will be employed to withdraw immunosuppression in kidney transplant recipients.
Study NCT06336863 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Immunosuppression Taper
Description: An immunosuppression taper will be employed over a 12-month period for those that are deemed immune quiescent.
Study NCT05428722 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: deep breathing exercises with a incentive spirometer
Description: Deep breathing exercise will be explained to the patients with an incentive spirometer (IS), it will be demonstrated in practice and it will be applied from the first day of hospitalization in addition to routine treatment and care. The patient will be informed about whether they are doing it right and their questions will be answered. It will be ensured that the patients start after breakfast in the morning and make 5-10 inspirations, hold her/his breath for 3 seconds and 5-10 expirations per hour with IS until they fall asleep. The research nurse will warn the patients that they should do the exercise every hour, and the alarms of the patients' mobile phones will be set to ring every hour to be a warning. The start and end time of the exercise will be decided together with the patient, and usually the time of waking and going to bed will be taken into account.
Study NCT05462561 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT05462561 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotic Vascularized Composite Bladder Allograft Transplantation
Description: Undergo robotic VCBA transplantation.
Study NCT04574193 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: digital therapeutic for substance use disorders
Description: The Continuing Care application (app) is a HIPAA-compliant, mobile-friendly, software program designed to meet the recovery and personal support needs of probationers and parolees with SUDs who are at elevated risk of relapse, re-arrest, and incarceration.
Study NCT04574193 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment As Usual
Description: 12-weeks of weekly group cognitive behavioral therapy
Study NCT05258942 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: Blood samples will be collected within 30 days before scheduled surgical / interventional therapy for Heart Failure. The study will not impact patient treatment in any way.
Study NCT05003648 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pramipexole
Description: Participants will be started on 0.125 mg pramipexole for the first week. If this dose is well tolerated but not effective, the dose can be increased to 0.25 mg for the following week. If this dose is well tolerated but not effective, the dose can be further increased to 0.5 mg for the remainder of the 2-month period.